Cargando…
Safety of BNT162b2 mRNA COVID-19 vaccine in patients with mast cell disorders
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Academy of Allergy, Asthma & Immunology
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249677/ https://www.ncbi.nlm.nih.gov/pubmed/34224924 http://dx.doi.org/10.1016/j.jaip.2021.06.032 |
| _version_ | 1783716945022943232 |
|---|---|
| author | Rosman, Yossi Lavi, Noa Meir-Shafrir, Keren Lachover-Roth, Idit Cohen-Engler, Anat Mekori, Yoseph A. Confino-Cohen, Ronit |
| author_facet | Rosman, Yossi Lavi, Noa Meir-Shafrir, Keren Lachover-Roth, Idit Cohen-Engler, Anat Mekori, Yoseph A. Confino-Cohen, Ronit |
| author_sort | Rosman, Yossi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8249677 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | American Academy of Allergy, Asthma & Immunology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82496772021-07-02 Safety of BNT162b2 mRNA COVID-19 vaccine in patients with mast cell disorders Rosman, Yossi Lavi, Noa Meir-Shafrir, Keren Lachover-Roth, Idit Cohen-Engler, Anat Mekori, Yoseph A. Confino-Cohen, Ronit J Allergy Clin Immunol Pract Clinical Communications American Academy of Allergy, Asthma & Immunology 2021-09 2021-07-02 /pmc/articles/PMC8249677/ /pubmed/34224924 http://dx.doi.org/10.1016/j.jaip.2021.06.032 Text en © 2021 American Academy of Allergy, Asthma & Immunology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Clinical Communications Rosman, Yossi Lavi, Noa Meir-Shafrir, Keren Lachover-Roth, Idit Cohen-Engler, Anat Mekori, Yoseph A. Confino-Cohen, Ronit Safety of BNT162b2 mRNA COVID-19 vaccine in patients with mast cell disorders |
| title | Safety of BNT162b2 mRNA COVID-19 vaccine in patients with mast cell disorders |
| title_full | Safety of BNT162b2 mRNA COVID-19 vaccine in patients with mast cell disorders |
| title_fullStr | Safety of BNT162b2 mRNA COVID-19 vaccine in patients with mast cell disorders |
| title_full_unstemmed | Safety of BNT162b2 mRNA COVID-19 vaccine in patients with mast cell disorders |
| title_short | Safety of BNT162b2 mRNA COVID-19 vaccine in patients with mast cell disorders |
| title_sort | safety of bnt162b2 mrna covid-19 vaccine in patients with mast cell disorders |
| topic | Clinical Communications |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249677/ https://www.ncbi.nlm.nih.gov/pubmed/34224924 http://dx.doi.org/10.1016/j.jaip.2021.06.032 |
| work_keys_str_mv | AT rosmanyossi safetyofbnt162b2mrnacovid19vaccineinpatientswithmastcelldisorders AT lavinoa safetyofbnt162b2mrnacovid19vaccineinpatientswithmastcelldisorders AT meirshafrirkeren safetyofbnt162b2mrnacovid19vaccineinpatientswithmastcelldisorders AT lachoverrothidit safetyofbnt162b2mrnacovid19vaccineinpatientswithmastcelldisorders AT cohenengleranat safetyofbnt162b2mrnacovid19vaccineinpatientswithmastcelldisorders AT mekoriyosepha safetyofbnt162b2mrnacovid19vaccineinpatientswithmastcelldisorders AT confinocohenronit safetyofbnt162b2mrnacovid19vaccineinpatientswithmastcelldisorders |